x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001305
| Product Information | |
|---|---|
| Product Name | Human Serpin A12 ELISA Kit |
| Species | Human |
| Description | Human Serpin A12 ELISA Kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of Serpin A12 protein in cit plasma, edta plasma, hep plasma, saliva, and serum. It uses our proprietary ELISA technology. Quantitate Human Serpin A12 with 3.12 pg/ml sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
| Sample Types | Saliva, Serum, Hep Plasma, Edta Plasma, Cit Plasma |
| Detection Range | 19.53 pg/mL - 1250 pg/mL |
| Sensitivity | 3.12 pg/mL |
| Precision | CV: < 10% |
| Target Information | |
|---|---|
| Target Name | SERPINA12 |
| UniProt No. | Q8IW75 |
| Gene ID | 145264 |
| Target Description | May modulates insulin action conceivably only in the presence of its yet undefined target proteases in white adipose tissues. |
| Alternative Names | ENSG00000165953; OL 64; OL-64; OL64; Serine (or cysteine) proteinase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 12; Serpin A12; Serpin A12 precursor; Serpin peptidase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 12; Serpina12; SPA12_HUMAN; Vaspin; Visceral adipose specific serpin; Visceral adipose tissue derived serine protease inhibitor; Visceral adipose tissue-derived serine protease inhibitor; Visceral adipose-specific serpin |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
